For the uninitiated, Plague Inc. is a funereally unsettling yet addictive disease simulator game where the player tries to wipe out humanity by creating and evolving plagues of bacteria, viruses or even…
Tag: Virus
MERS vaccine could be on the horizon
A vaccine for the Middle East Respiratory Syndrome (MERS) coronavirus could be on the horizon with scientists revealing that a vaccine developed using synthetic DNA successfully induced protective immunity in animals against…
Study confirms theory that ‘leaky’ vaccines support evolution of dangerous viruses
Researchers have confirmed for the first time ever that ‘leaky’ or ‘imperfect’ vaccines enable viruses to evolve into more dangerous variants that put unvaccinated individuals at greater risk of more severe versions…
Early antiretroviral therapy helps suppress HIV and prevents transmission
Researchers have concluded in a decade long clinical trail that early intervention could help suppress HIV as well as prevent its sexual transmission in heterosexual couples. The results of an international clinical…
Tekmira suspends Ebola vaccine development; says will concentrate on HBV instead
Tekmira Pharmaceuticals Corporation has announced that it is suspending development of its Ebota vaccine and instead will channel all its resources in development of a cure for chronic hepatitis B virus infection….
Novel therapy sees viruses kill cancer cells; clinical trials announced
In a development that puts us very close to a possible therapy for cancer, researchers have devised a novel way of killing cancer cells using two viruses. The same team, in their…
Vancouver 2010 Olympic Games visitors brought measles to B.C.
University of British Columbia researchers have attributed the 2010 measles outbreak in which 84 cases of measures were recorded to the Vancouver 2010 Olympic Games. The study, published in the Journal of…
Researchers just one step away from possible dengue cure
Researchers at an arm’s length from a possible cure or treatment of dengue thanks to a discovery of an antibody that neutralises dengue virus serotype 2 (DENV-2). With over 400 million people…
Are we closing-in on HIV vaccine? New vaccine shows promise in primates
Researchers have revealed success in lab experiments involving non-human primates (NHPs) and a HIV vaccine stating that their their HIV-1 vaccine regimen which involved a viral vector boosted with a purified envelope…
Just a single mutation helped last year’s flu virus to gain advantage over vaccine
Flu vaccine for the year 2014-2015 wasn’t as effective as its predecessors and researchers have finally revealed the reason behind that. According to a study published in Cell Reports just a single…
New Ebola diagnostic test could give a major boost in fight against the disease
Though Ebola may have slowed down as far as new infections are concerned, the danger is far from over and one of the major steps in fighting against the disease is its…
Ebola drug trail stopped as TKM-Ebola-Guinea shows no overall benefit
Tekmira Pharmaceuticals Corporation has revealed that the Phase II clinical trial of its Ebola treatment TKM-Ebola-Guinea has reached a predefined statistical endpoint and that they have closed the enrollment indicating that the…
Ebola virus didn’t mutate as fast as previously thought, study finds
A study led by Public Health England (PHE) has established that the Ebola virus responsible for the latest outbreak in West Africa didn’t mutate as fast as previously thought and if compared…
Genetically engineered herpes virus capable of halting skin cancer
Phase III of a viral immunotherapy wherein genetically engineered herpes virus were used against skin cancer has shown promising results with the herpes virus able to halt the progression of skin cancer…
Researchers develop vaccines for H5N1, H7N9 avian influenza strains
Researchers with Kansas State University have developed vaccines for two new strains of influenza strains – H5N1 and H7N9 – which can be transmitted from poultry to humans. Researchers employed a new…